TGFbeta RI is a protein encoded by the TGFBR1 gene. TGFbeta RI is localised to the cell membrane. It is involved in apoptotic pathways and the PAK pathway. It is a heteromeric complex that transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation, differentiation and extracellular matrix production. TGFbeta RI is expressed in all human tissues and is most abundant in the placenta. Mutations in the TGFBR1 gene may result in Loeys-Dietz syndrome. STJ91351 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This primary antibody specifically binds to endogenous TGFbeta R protein which only binds about S165 when S165 is phosphorylated.
应用类型
IF, IHC-P, ELISA, WB
免疫原
Synthesized peptide derived from human TGFBeta RI around the phosphorylation site of S165. Location: 100-180aa.
来源宿主
Rabbit
反应性
该TGFBR1 抗体 (Phospho-Ser165)的反应性请参考该产品的说明书
保存建议
Store at -20°C. Avoid repeated freeze/thaw cycles.
其他
Aviva Systems Biology总部位于加利福尼亚州圣迭戈，在中国北京设有办公室，专注于为研究需求提供多克隆和单克隆抗体、ELISA试剂盒、蛋白质和定制服务。Aviva Systems Biology生产了24,000种经过验证的多克隆抗体，并提供近20,000种ELISA试剂盒，定制实验室服务包括蛋白表达和纯化、抗体开发，以及ELISA的开发、验证和生产。Aviva Systems Biology为与独特物种和靶标相关的研究提供独特工具，研究领域包括转录因子、癌症、心血管、细胞生物学、DNA损伤和修复、表观遗传学、信号转导、细胞分化、干细胞生物学等等。
